Company logo

SGRY - Surgery Partners, Inc.

NASDAQ -> Healthcare -> Medical Care Facilities
Brentwood, United States
Type: Equity

SGRY price evolution
SGRY
(in millions $) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $213.5 $185.2 $195.9 $236
Short term investments
Net receivables $523.4 $494.3 $496.4 $462.8
Inventory $80.9 $77 $75.2 $69.4
Total current assets $1012.5 $895.9 $895 $876.2
Long term investments $227.1 $188.7 $184.1 $196.3
Property, plant & equipment $1272.7 $1240.5 $1224 $1184.2
Goodwill & intangible assets $4858.5 $4451.1 $4380.8 $4301
Total noncurrent assets $6476.1 $6079.7 $5981.7 $5903.9
Total investments $227.1 $188.7 $184.1 $196.3
Total assets $7488.6 $6975.6 $6876.7 $6780.1
Current liabilities
Accounts payable $174 $174.1 $171.8 $148.8
Deferred revenue
Short long term debt $92.4 $77.2 $73.3 $62.1
Total current liabilities $551.8 $523.4 $523 $501.4
Long term debt $3297.3 $3044.3 $2950.7 $2881.1
Total noncurrent liabilities $3760.5 $3414.3 $3319.2 $3292.2
Total debt $3389.7 $3121.5 $3024 $2943.2
Total liabilities $4312.3 $3937.7 $3842.2 $3793.6
Shareholders' equity
Retained earnings -$597.1 -$581.6 -$569.2 -$568.2
Other shareholder equity $37.1 $52 $57.5 $77
Total shareholder equity $1952.4 $1967.3 $1987.2 $2004.6
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $195.9 $282.9 $389.9 $317.9
Short term investments
Net receivables $496.4 $456.3 $430.2 $382.2
Inventory $75.2 $71.4 $61.1 $56.4
Total current assets $895 $921 $946.1 $801.5
Long term investments $184.1 $190.3 $88.7 $90.3
Property, plant & equipment $1224 $1155.7 $953.8 $854.7
Goodwill & intangible assets $4380.8 $4179.4 $3955.5 $3514.9
Total noncurrent assets $5981.7 $5761.1 $5171.5 $4611.7
Total investments $184.1 $190.3 $88.7 $90.3
Total assets $6876.7 $6682.1 $6117.6 $5413.2
Current liabilities
Accounts payable $171.8 $151.6 $124.9 $100.2
Deferred revenue $3.2 $64.4 $109.8
Short long term debt $73.3 $62.8 $60.4 $64.4
Total current liabilities $523 $493.4 $536.8 $556.8
Long term debt $2950.7 $2559 $3194 $3093.3
Total noncurrent liabilities $3319.2 $3247.8 $3611.2 $3974.3
Total debt $3024 $2893.2 $3254.4 $3157.7
Total liabilities $3842.2 $4683.9 $4148 $4531.1
Shareholders' equity
Retained earnings -$569.2 -$557.3 -$502.7 -$431.8
Other shareholder equity $57.5 $76.2 -$31.5 -$61
Total shareholder equity $1987.2 $1998.2 $1089 $115.6
(in millions $) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $762.1 $717.4 $735.4 $674.1
Cost of revenue $582.9 $562.1 $541.8 $508.3
Gross Profit $179.2 $155.3 $193.6 $165.8
Operating activities
Research & development
Selling, general & administrative $40.3 $33.2 $20.9 $36.8
Total operating expenses $93.7 $82 $81.5 $86.7
Operating income $85.5 $73.3 $112.1 $79.1
Income from continuing operations
EBIT $40.9 $39.3 $53.7 $48
Income tax expense $4.9 $4.4 $6 $3.1
Interest expense $51.5 $47.3 $48.7 $49.8
Net income
Net income -$15.5 -$12.4 -$1 -$4.9
Income (for common shares) -$15.5 -$12.4 -$1 -$4.9
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $2743.3 $2539.3 $2225.1 $1860.1
Cost of revenue $2095.8 $1964.4 $1733.7 $1480.3
Gross Profit $647.5 $574.9 $491.4 $379.8
Operating activities
Research & development
Selling, general & administrative $120.9 $102.2 $104 $97.1
Total operating expenses $318.2 $227.3 $191.4 $207.6
Operating income $329.3 $347.6 $300 $172.2
Income from continuing operations
EBIT $180.8 $203.6 $160.6 $65.6
Income tax expense -$0.3 $23.3 $10.5 -$20.1
Interest expense $193 $234.9 $221 $201.8
Net income
Net income -$11.9 -$54.6 -$70.9 -$116.1
Income (for common shares) -$11.9 -$54.6 -$81.2 -$155.6
(in millions $) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$15.5 -$12.4 -$1 -$4.9
Operating activities
Depreciation $44.5 $42.7 $39.9 $37.4
Business acquisitions & disposals -$210 -$54.6 -$31.2 -$5.3
Stock-based compensation $15.1 $4.9 $4.5 $4.4
Total cash flows from operations $82.8 $40.7 $62.6 $104.6
Investing activities
Capital expenditures -$26.9 -$19.5 -$19.8 -$19.2
Investments $4.3 -$2 $0.3 -$0.8
Total cash flows from investing -$244.1 -$83.1 -$58.1 -$25.6
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $234.4 $72.3 -$15.6 $17.2
Total cash flows from financing $189.6 $31.7 -$44.6 -$20.4
Effect of exchange rate
Change in cash and equivalents $28.3 -$10.7 -$40.1 $58.6
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$11.9 -$54.6 -$70.9 -$116.1
Operating activities
Depreciation $153.3 $149.6 $137.9 $134.2
Business acquisitions & disposals -$80 -$146.4 -$285.8 -$104.6
Stock-based compensation $17.7 $18.4 $17.4 $13.2
Total cash flows from operations $293.8 $158.8 $87.1 $246.9
Investing activities
Capital expenditures -$63 -$67.7 -$51.6 $15.6
Investments -$48.9 -$82.3 $5.4
Total cash flows from investing -$225.6 -$307.9 -$331.7 -$88.4
Financing activities
Dividends paid
Sale and purchase of stock $857.7 $554.2
Net borrowings -$4.8 -$655.5 -$55.5 $204.6
Total cash flows from financing -$155.2 $42.1 $316.3 $66.7
Effect of exchange rate
Change in cash and equivalents -$87 -$107 $71.7 $225.2
Fundamentals
Market cap $3.87B
Enterprise value $7.04B
Shares outstanding 127.12M
Revenue $2.89B
EBITDA $346.40M
EBIT $181.90M
Net Income -$33.80M
Revenue Q/Q 14.16%
Revenue Y/Y 8.55%
P/E ratio -114.37
EV/Sales 2.44
EV/EBITDA 20.33
EV/EBIT 38.71
P/S ratio 1.34
P/B ratio 2.02
Book/Share 15.07
Cash/Share 1.68
EPS -$0.27
ROA -0.48%
ROE -1.71%
Debt/Equity 1.93
Net debt/EBITDA 11.83
Current ratio 1.83
Quick ratio 1.69